Stem cell transplant shrinks tumour metastases

LONDON, 14 September (SPIS MedWire). Stem cell transplantation may offer hope to patients with advanced kidney cancer - usually considered an incurable illness. According to a report in today's New England Journal of Medicine, 19 patients with metastatic renal cell carcinoma, which had not responded to conventional therapy, received low-dose chemotherapy and immunosuppression followed by stem cell transplantation from a related donor. In seven patients there was shrinkage of metastases, and thre

Written byScience Now
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

LONDON, 14 September (SPIS MedWire). Stem cell transplantation may offer hope to patients with advanced kidney cancer - usually considered an incurable illness. According to a report in today's New England Journal of Medicine, 19 patients with metastatic renal cell carcinoma, which had not responded to conventional therapy, received low-dose chemotherapy and immunosuppression followed by stem cell transplantation from a related donor. In seven patients there was shrinkage of metastases, and three showed complete disappearance of all secondary tumours.

The researchers noted that the benefits of the treatment were not immediate: even patients who eventually experienced success with the treatment had their tumours grow immediately after transplantation, when their immune systems were still weak. Regression of tumours did not occur until four months after cessation of immune-suppressing drugs, and the procedure was not risk-free, with two recipients dying from transplant-related causes. The authors conclude that, for the time being, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control